Clémence Henon

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 920 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +5

PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer

Roman M. Chabanon, Gareth Muirhead, Dragomir B. Krastev et al. · Journal of Clinical Investigation · 2018 · 324 citations · Full text

Life Sciences, Immunology, Oncology +17

Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Lizza Hendriks, Clémence Henon, Édouard Auclin et al. · Journal of Thoracic Oncology · 2019 · 242 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

Roman M. Chabanon, Daphné Morel, Thomas Eychenne et al. · Cancer Research · 2021 · 113 citations · Full text

Medicine, Cancer Biology, Oncology +14

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

Lizza Hendriks, Gerben Bootsma, Jean Mourlanette et al. · European Journal of Cancer · 2019 · 65 citations · Full text

Medicine, Immunology, Oncology +16